NDLI: Pengaruh Pemberian Kombinasi Ekstrak Tapak Dara (catharanthus Roseus) Dan Ekstrak Temulawak (curcuma Xanthorhiza) Terhadap Hepar Mencit C3h Yang Telah Diinokulasi Sel Adenocarcinoma Mammae

Please wait, while we are loading the content...

Pengaruh Pemberian Kombinasi Ekstrak Tapak Dara (catharanthus Roseus) Dan Ekstrak Temulawak (curcuma Xanthorhiza) Terhadap Hepar Mencit C3h Yang Telah Diinokulasi Sel Adenocarcinoma Mammae

Content Provider	Semantic Scholar
Author	Islamiyati, Yomi
Copyright Year	2006
Abstract	Background : Lots of studies said that the single used of tapak dara and temulawak did not have toxic effects, but the combination should be studied. The side effects could be happen in liver as the place where a drug become detoxificated and metabolized. Besides, the use of combination could increase the interaction between them. Objective : To find out the effect of tapak dara and combination between tapak dara and temulawak on the C3H mice liver in macroscopic and microscopic. Method : This study is an experimental with design ‘post test only control group design’. 15 C3H mices were divided into three groups. The first group was inoculated by adenocarcinoma mammae(K), second group was inoculated by adenocarcinoma mammae and was given tapak dara(P1), and the third group was inoculated by adenocarcinoma mammae and was given combination of tapak dara and temukawak(P2). Treatment was given for a month. The termination was done on the last day, the liver was taken to be measured and scored histopatologically. Data were analized by One Way ANOVA test. Result : The study showed that there is significant difference of liver weight mean, with p=0,000. Outcome of One Way ANOVA test showed no significant differences between all groups in normally hepatocelluler (p=0,063), parenchymatous degeneration (p=0,051), hydropic degeneration (p=0,503) and fatty change of the liver (p=0,155) Conclusion : Administration of tapak dara(25 mg/ml) and the combination of tapak dara(19,5 mg/ml) and temulawak(10,4 mg/ml) showed significant difference in liver weight but not the histopathological appearance. Keywords : Tapak dara, temulawak combination, side effects, liver.
File Format	PDF HTM / HTML
Alternate Webpage(s)	http://eprints.undip.ac.id/21034/1/Yomi.pdf
Language	English
Access Restriction	Open
Content Type	Text
Resource Type	Article

Central Library (ISO-9001:2015 Certified)
Indian Institute of Technology Kharagpur
Kharagpur, West Bengal, India | PIN - 721302

See location in the Map
03222 282435
Mail: support@ndl.gov.in

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in